Research Directory

EFPIA argues for better use of oncology endpoints

Read more

ASCO 2023 Strong data for lung and breast cancer drugs

Read more

New opportunities for small molecules in cancer

Read more

Development timelines for new oncology drugs

Read more

FDA guides on accelerated approvals in oncology

Read more

Oncology pipeline marked by multiple therapy types

Read more

Immunocore and Gadeta probe gamma delta T cell receptors

Read more

Novel oncology drugs approved in a year of change

Read more

Progressive increase in oncology drug approvals

Read more

Checkpoint inhibitors are focus at ESMO

Read more